Core Cap Advisors, LLC Collegium Pharmaceutical, Inc Call Options Transaction History
Core Cap Advisors, LLC
- $2.18 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding COLL
# of Institutions
254Shares Held
37.2MCall Options Held
61.1KPut Options Held
5.8K-
Black Rock Inc. New York, NY5.79MShares$169 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY3MShares$87.4 Million2.57% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$76.9 Million1.67% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.25MShares$65.5 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA1.63MShares$47.6 Million0.01% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $994M
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...